Results 11 to 20 of about 924,359 (286)
SARS‐CoV‐2 and hypertension [PDF]
Physiological Reports, 2021 The objective of this review is to give an overview of the pathophysiological effects of the Coronavirus Disease 2019 (COVID‐19) in relation to hypertension (HT), with a focus on the Renin–Angiotensin–Aldosterone System (RAAS) and the MAS receptor. HT is
Briyanth Ravichandran +5 more
doaj +4 more sources
Gefässchirurgie, 2020 The year 2020 has been marked by the novel coronavirus, named Severe Acute Respiratory Syndrome 2 (SARS-CoV-2), which causes coronavirus disease COVID-19. The World Health Organization (WHO) declared a global pandemic on the 11th of March 2020 due to the spread of this very contagious virus throughout the world.
Steinbauer, M., Böckler, D.
+9 more sources
Infectious Disease Clinics of North America, 2022 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in 2020 and has led to an unprecedented global pandemic. Understanding the virology behind SARS-CoV-2 infection has provided key insights into our efforts to develop antiviral agents and control the COVID-19 pandemic.
Li, Yijia, Li, Jonathan Z.
openaire +3 more sources
Drug Repurposing Against SARS-CoV-1, SARS-CoV-2 and MERS-CoV [PDF]
Future Microbiology, 2021 Since the beginning of the COVID-19 pandemic, large in silico screening studies and numerous in vitro studies have assessed the antiviral activity of various drugs on SARS-CoV-2. In the context of health emergency, drug repurposing represents the most relevant strategy because of the reduced time for approval by international medicines agencies, the ...
Aherfi, Sarah +6 more
openaire +3 more sources
Epidemiology of SARS-CoV-2 [PDF]
Infection, 2020 Abstract Purpose SARS-CoV-2 is a recently emerged ß-coronavirus. Here we present the current knowledge on its epidemiologic features. Methods Non-systematic review.
Salzberger, Bernd +7 more
openaire +4 more sources
Estimating SARS-CoV-2 seroprevalence
Journal of the Royal Statistical Society Series A: Statistics in Society, 2023 Abstract Governments and public health authorities use seroprevalence studies to guide responses to the COVID-19 pandemic. Seroprevalence surveys estimate the proportion of individuals who have detectable SARS-CoV-2 antibodies. However, serologic assays are prone to misclassification error, and non-probability sampling may induce ...
Samuel P Rosin +3 more
openaire +4 more sources
SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge
Measurement, 2021 The highly pathogenic MERS-CoV, SARS-CoV and SARS-CoV-2 cause acute respiratory syndrome and are often fatal. These new viruses pose major problems to global health in general and primarily to infection control and public health services. Accurate and selective assessment of MERS-CoV, SARS-CoV and SARS-CoV-2 would assist in the effective diagnosis of ...
Ezhilan, Madeshwari +2 more
openaire +2 more sources
Scientific Reports, 2022 Loop-mediated isothermal amplification is known for its high sensitivity, specificity and tolerance to inhibiting-substances. In this work, we developed a device for performing real-time colorimetric LAMP combining the accuracy of lab-based quantitative ...
G. Papadakis +17 more
doaj +1 more source
Acute parkinsonism secondary to SARS Cov 2 infection. [PDF]
Batna Journal of Medical Sciences, 2023 SARS Cov 2 or Corona virus is a respiratory virus, responsible for a new pandemic since 2019. Main symptoms revolve around respiratory manifestations. Nevertheless, many extra-respiratory attacks are attributed to it.
Mohamed Islam Kediha +3 more
doaj +1 more source